BSE filing, NSE: SILVOAK. Summary written from the filing by ALFA Finder's alert engine.
Silver Oak (India) Ltd: key numbers
- Share price
- ₹69.00
- Market cap
- ₹26.15 Cr
- Revenue (annual)
- ₹0.00 Cr
- Net profit (annual)
- ₹-1.47 Cr
- P/E (TTM)
- -16.6×Sector 26.8×
- Promoter holding
- 64.71%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Silver Oak (India) Ltd
All →Silver Oak (India) Annual General Meeting
Silver Oak (India) Limited held its 42nd Annual General Meeting on September 29, 2026. Shareholders considered the adoption of audited financial statements and director appointments.
Silver Oak (India) Other Announcement
Silver Oak (India) Limited has informed shareholders whose email addresses are not registered that the 42nd Annual Report and AGM Notice are now available online.
Silver Oak (India) Annual Report
Silver Oak (India) Limited submitted its 42nd Annual Report for the financial year 2025-26. The report includes corporate information, the director's message, and audited financial statements.
Silver Oak (India) Annual General Meeting
Silver Oak (India) Limited scheduled its 42nd Annual General Meeting for September 29, 2026. Key agenda items include adopting financial statements and appointing directors.
Silver Oak (India) Management Change
Silver Oak (India) Limited has appointed Mr. Ajay Jalota as a Non-Executive Independent Director for a 60-month term, effective September 3, 2026.
Silver Oak (India) Board Meeting Outcome
Silver Oak India Ltd announced the outcome of its board meeting held on 3rd September, 2026, including director appointments and the 42nd AGM convocation.
Other other announcement announcements
All →Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.
Avience Biomedicals Other Announcement
Avience Biomedicals confirmed corporate governance compliance is not applicable, as it is SME-listed on NSE Emerge. No quarterly governance report is required for September 2026.